Phytoestrogens – classification, occurrence and significance in the prevention and treatment of osteoporosis

Ryszard Kocjan; Maciej Strzemski; Ireneusz Sowa; Andrzej Polski; Wojciech Szwerc; Ryszard Świeboda; Tomasz Blicharski

Authors

Ryszard Kocjan Department of Analytical Chemistry, Medical University of Lublin, Poland Author https://orcid.org/0000-0002-4561-2911
Maciej Strzemski Department of Analytical Chemistry, Medical University of Lublin, Poland Author https://orcid.org/0000-0002-0039-4455
Ireneusz Sowa Department of Analytical Chemistry, Medical University of Lublin, Poland Author https://orcid.org/0000-0001-9346-6325
Andrzej Polski Department of Analytical Chemistry, Medical University of Lublin, Poland Author
Wojciech Szwerc Department of Analytical Chemistry, Medical University of Lublin, Poland Author https://orcid.org/0000-0003-3491-6319
Ryszard Świeboda Department of Inorganic Chemistry, Medical University of Lublin, Poland Author https://orcid.org/0000-0002-9669-2341
Tomasz Blicharski Orthopaedics and Rehabilitation Clinic, Medical University of Lublin, Poland Author https://orcid.org/0000-0001-9747-8817

Keywords:

phytoestrogens, osteoporosis, Glycine max (L.) Merr., Cimicifuga racemosa Nutt., Pueraria lobata (Willd.) Ohwi

Abstract

The object of this publication is the review of the literature concerning the classification, sources of phytoestrogens and their medicinal significance. Phytoestrogens are not a group of compounds, which are separated on the basis of chemical affinity, but due to the physiological effects they have on the human body. They are present in many representatives of the world's flora and form together with mykoestrogens and xenoestrogens a group of environmental estrogens. Phytoestrogens fulfill a series of important functions in a living organisms, for example their presence in a diet may decrease the probability of many diseases including osteoporosis.

References

1. Arjmandi B., Khalil D., Smith B. et al.: Soy protein has a greater effect on bone in postmenopausal women not on hormone replacement therapy, as evidenced by reducing bone resorption and urinary calcium excretion. J. Clin. Endocrinol. Metab., 88, 1048, 2003.

2. Cornwell T., Cohick W., Raskin I.: Dietary phytoestrogens and health. Phytochem., 65, 995, 2004.

3. Delmonte P., Perry J., Rader J.: Determination of isoflavones in dietary supplements containing soy, Red Clover and kudzu: Extraction followed by basic or acid hydrolysis. J. Chromatogr. A, 1107, 60, 2006.

4. Foltyn W., Kos-Kudła B., Siemińska L. et al.: Osteoporoza i miażdżyca – wspólna etiopatogeneza? Endokr. Pol., 3, 316, 2003.

5. Gehm B., McAndrews J., Chien P., Jameson J.L.: Resveratrol, a polyphenolic compound fund in grapes and wine, is an agonist for the estrogen receptor. Proc. Natl. Acad. Sci. USA, 94, 14138, 1997.

6. Głowniak K., Widelski J., Skalicka-Woźniak K.: Lucerna – niedoceniony surowiec leczniczy. Panacea, 3, 10, 2007.

7. Ibarreta D., Daxenberger A., Meyer Hhd.: Possible health impact of phytoestrogens and xenoestrogens in food. Apmis., 109, 161, 2001.

8. Janeczko Z., Jurczyszyn A., Bochenek B.: Właściwości biologiczne resweratrolu i możliwości jego stosowania w terapii szpiczaka mnogiego. Panacea, 2, 9, 2009.

9. Kerstetter J. E., Wall D.E., O’Brien K.O. et al.: Meat and soy protein affect calcium homeostasis in healthy women. J. Nutr., 136, 1890, 2006.

10. Kohlmünzer S.: Farmakognozja. PZWL. Warszawa 2007.

11. Kraszewska O., Nynca A., Kamińska B., Ciereszko R.: Fitoestrogeny. I. Występowanie, metabolizm i znaczenie biologiczne u samic. Post. Biol. Kom., 1, 189, 2007.

12. Kraszewska O., Nynca A., Kamińska B., Ciereszko R.: Fitoestrogeny. II. Wewnątrzkomórkowy mechanizm działania w układzie rozrodczym samicy. Post. Biol. Kom., 1, 207, 2007.

13. Lamer-Zarawska E., Kowal-Gierczak B., Niedworok J.: Fitoterapia i leki roślinne. PZWL. Warszawa 2007.

14. Murkies Al., Wilcox G., Davis Sr.: Phytoestrogens. J. Clin. Endocrinol. Metab., 83, 297, 1998.

15. Nieradko-Iwanicka B., Borzęcki A.: Osteoporoza jako problem pediatryczny. Probl. Hig. Epidemiol., 90, 27, 2009.

16. Olas B.: Antyoksydanty obecne w diecie w walce z miażdżycą. Kosmos, 2, 249, 2003.

17. Oleszek W., Stochmal A.: Triterpene saponins and flavonoids in the seeds of Trifolium species. Phytochem., 61, 165, 2002.

18. Ożarowski A.: Ziołowa terapia zastępcza w okresie przekwitania. Panacea, 2, 16, 2004.

19. Prescha A., Biernat J.: Wpływ fitoestrogenów pokarmowych na organizm człowieka. Bromat. Chem. Toksykol., 4, 941, 2008.

20. Rahnama M., Błoniarz J., Zaręba S., Świątkowski W.: Wpływ fitoestrogenów na gęstość mineralną kości (BMD żuchwy, kręgosłupa, kości udowej). Bromat. Chem. Toksykol., 3, 642, 2009.

21. Strzelecka H., Kowalski J.: Encyklopedia zielarstwa i ziołolecznictwa. PWN. Warszawa 2000.

22. Wu Q., Wang M., Simon J.: Determination of isoflavones in red clover and related species by high-performance liquid chromatography combined with ultraviolet and mass spectrometric detection. J. Chromatogr. A, 1016, 195, 2003.

23. Zgórka G.: Studies on Phytoestrogenic and Nonphytoestrogenic Compounds in Trifolium incarnatum L. and Other Clover Species Using Pressurized Liquid Extraction and High Performance Column Liquid Chromatography with Photodiode-Array and Fluorescence Detection. J. AOAC Int., 94, 22, 2011.

Phytoestrogens – classification, occurrence and significance in the prevention and treatment of osteoporosis

Authors

Keywords:

Abstract

References

Downloads

Published

Issue

Section

License

sidebar

Language